Arrowhead Pharmaceuticals Inc [NASDAQ: ARWR] gained 24.23% or 5.1 points to close at $26.15 with a heavy trading volume of 6689864 shares.
The daily chart for ARWR points out that the company has recorded 14.79% gains over the past six months.
If we look at the average trading volume of 1.19M shares, ARWR reached to a volume of 6689864 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Arrowhead Pharmaceuticals Inc [ARWR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARWR shares is $44.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARWR stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Arrowhead Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on June 05, 2024. While these analysts kept the previous recommendation, BofA Securities raised their target price to Buy. The new note on the price target was released on December 04, 2023, representing the official price target for Arrowhead Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $33, while Citigroup analysts kept a Neutral rating on ARWR stock.
The Average True Range (ATR) for Arrowhead Pharmaceuticals Inc is set at 1.55, with the Price to Sales ratio for ARWR stock in the period of the last 12 months amounting to 915.73. The Price to Book ratio for the last quarter was 17.54, with the Price to Cash per share for the same quarter was set at 5.48.
Trading performance analysis for ARWR stock
Arrowhead Pharmaceuticals Inc [ARWR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 39.76. With this latest performance, ARWR shares gained by 30.88% in over the last four-week period, additionally plugging by 14.79% over the last 6 months – not to mention a drop of -9.58% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARWR stock in for the last two-week period is set at 74.51, with the RSI for the last a single of trading hit 80.81, and the three-weeks RSI is set at 69.33 for Arrowhead Pharmaceuticals Inc [ARWR]. The present Moving Average for the last 50 days of trading for this stock 19.95, while it was recorded at 20.56 for the last single week of trading, and 24.43 for the last 200 days.
Arrowhead Pharmaceuticals Inc [ARWR]: A deeper dive into fundamental analysis
Arrowhead Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.74 and a Current Ratio set at 6.74.
Arrowhead Pharmaceuticals Inc [ARWR]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARWR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Arrowhead Pharmaceuticals Inc go to 7.33%.
An analysis of Institutional ownership at Arrowhead Pharmaceuticals Inc [ARWR]
There are presently around $79.71%, or 83.43%% of ARWR stock, in the hands of institutional investors. The top three institutional holders of ARWR stocks are: BLACKROCK INC. with ownership of 15.68 million shares, which is approximately 12.7211%. VANGUARD GROUP INC, holding 12.21 million shares of the stock with an approximate value of $$317.44 million in ARWR stocks shares; and VANGUARD GROUP INC, currently with $$231.02 million in ARWR stock with ownership which is approximately 7.21%.
